MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17568919.2026.2669605

Медицинская библиотека · Future medicinal chemistry · 2026

Tailored pyrazolone-oxadiazole frameworks: synthetic execution, functional enzyme studies, and comprehensive docking-DFT-based antidiabetic investigation.

Iqbal Tayyiaba, Habib Mohamed A, Khan Shoaib, Rehman Wajid, Bibi Aisha, Hussain Rafaqat, Ibrahim Ahmed B M, Kayumov Khasan

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIM: This study aimed to design, synthesize, and biologically evaluate a novel series of pyrazolone-derived oxadiazole Schiff base derivatives as potential anti-diabetic agents.

MATERIALS AND

METHODS

A library of Schiff base derivatives was synthesized and structurally characterized using ¹H NMR, ¹³C NMR, and HREI-MS techniques. The anti-diabetic potential was evaluated through in vitro α-amylase and α-glucosidase inhibition assays. The most active compounds were further analyzed by molecular docking and molecular dynamics (MD) simulations to explore binding interactions and stability within enzyme active sites. Density functional theory (DFT) calculations were performed to assess electronic properties, including HOMO-LUMO energy gaps, while ADMET predictions were conducted to evaluate pharmacokinetic and drug-likeness profiles.

RESULTS

The compounds exhibited moderate to excellent inhibitory activity against both enzymes. Among them, analogs 1-3 showed the highest potency, with analog 3 identified as the lead compound, displaying IC₅₀ values of 3.10 ± 0.20 µM (α-amylase) and 3.60 ± 0.20 µM (α-glucosidase). Computational studies supported strong binding affinity and stable interactions, while DFT and ADMET analyses indicated favorable electronic and pharmacokinetic properties.  .

CONCLUSION

These findings highlight pyrazolone-oxadiazole Schiff base derivatives, particularly analog 3, as promising anti-diabetic candidates for further optimization and preclinical studies.

Для цитирования: Iqbal Tayyiaba, Habib Mohamed A, Khan Shoaib, Rehman Wajid, Bibi Aisha, Hussain Rafaqat, Ibrahim Ahmed B M, Kayumov Khasan. Tailored pyrazolone-oxadiazole frameworks: synthetic execution, functional enzyme studies, and comprehensive docking-DFT-based antidiabetic investigation.. Future medicinal chemistry. 2026. DOI: 10.1080/17568919.2026.2669605.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.